Pallas Capital Advisors LLC Regeneron Pharmaceuticals, Inc. Transaction History

Pallas Capital Advisors LLC

  • $2.31 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 20, 2022
SELL
$595.12 - $698.43 $316,008 - $370,866
-531 Closed
0 $0
Q4 2021

Feb 01, 2022
SELL
$543.48 - $670.97 $126,630 - $156,336
-233 Reduced 30.5%
531 $330,000
Q3 2021

Nov 12, 2021
BUY
$574.03 - $680.96 $438,558 - $520,253
764 New
764 $498,000

Others Institutions Holding REGN

# of Institutions
1,426
Shares Held
82.1M
Call Options Held
835K
Put Options Held
1.46M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $112B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email